AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30227659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 27613934 — intervention group
Group type: EXPERIMENTAL
Intervention: Active progesterone (PRO; 200mg twice a day)
Number of subjects: 46
Study 27613934 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 46
Study 25630357 — intervention group
Group type: EXPERIMENTAL
Intervention: Couplelinks online intervention
Number of subjects: 80
Study 25630357 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 80
Study 22986643 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment for 6 months
Number of subjects: 16
Study 22986643 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid subjects (control group)
Number of subjects: 16
Study 20067480 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice hydrolysate formula
Number of subjects: 72
Study 20067480 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 72
Study 20067480 — intervention group
Group type: COMPARATOR
Intervention: Extensively hydrolysed cow's milk formula
Number of subjects: 72
Study 20067480 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice hydrolysate formula (in children not co-sensitized to soy)
Number of subjects: 72
Study 20067480 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based formula (in children not co-sensitized to soy)
Number of subjects: 72
Study 18237596 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 155
Study 18237596 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 155
Study 16278080 — intervention group
Group type: EXPERIMENTAL
Intervention: SRL 172 (heat-killed Mycobacterium vaccae)
Number of subjects: 22
Study 16278080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 12916291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 12626207 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous suture
Number of subjects: 334
Study 12626207 — intervention group
Group type: COMPARATOR
Intervention: Intracutaneous suture
Number of subjects: 334
Study 12626207 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive surgical zipper
Number of subjects: 334
Study 9536981 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential compression devices (Group 1)
Number of subjects: 136
Study 9536981 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous heparin (Group 2)
Number of subjects: 136
Study 9536981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 136
Study 8021331 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 300 mg
Number of subjects: 111
Study 8021331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 2524573 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice containing zinc citrate and Triclosan
Number of subjects: 34
Study 2524573 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 34
Study 4900147 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ampicillin powder
Number of subjects: 130
Study 4900147 — intervention group
Group type: COMPARATOR
Intervention: Topical placebo powder (lactose)
Number of subjects: 130
Study 30826725 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent lullaby music intervention
Number of subjects: 66
Study 30826725 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 66
Study 27999056 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DOLU group, n = 37)
Number of subjects: 73
Study 27999056 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted PI (PI group, n = 36)
Number of subjects: 73
Study 27999056 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DOLU group)
Number of subjects: 73
Study 27999056 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted PI (PI group)
Number of subjects: 73
Study 26002297 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 0
Study 26002297 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 0
Study 22751031 — intervention group
Group type: EXPERIMENTAL
Intervention: TSCORE (time-stamped pain scores)
Number of subjects: 42
Study 22751031 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper numerical rating scale
Number of subjects: 42
Study 22751031 — intervention group
Group type: EXPERIMENTAL
Intervention: TSCORE
Number of subjects: 42
Study 22751031 — intervention group
Group type: EXPERIMENTAL
Intervention: TLOG (monitoring TENS use)
Number of subjects: 42
Study 20884221 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump without CA
Number of subjects: 81
Study 20884221 — intervention group
Group type: COMPARATOR
Intervention: On-pump with CA
Number of subjects: 81
Study 20006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (100 mcg)
Number of subjects: 60
Study 20006256 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study 17171539 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐based cognitive behavioural treatment for anxiety
Number of subjects: 47
Study 17171539 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 47
Study 15102141 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger
Number of subjects: 0
Study 15102141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sadness
Number of subjects: 0
Study 15102141 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral state
Number of subjects: 0
Study 11340513 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 10% povidone-iodine solution applied on the periocular skin and 5% povidone-iodine solution instilled on the forniceal conjunctiva the day before and one hour before surgery.
Number of subjects: 82
Study 11340513 — intervention group
Group type: COMPARATOR
Intervention: Usual perioperative disinfectant (control group).
Number of subjects: 82
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxyl
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 0
Study 9114989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 0
Study 9114989 — intervention group
Group type: COMPARATOR
Intervention: Dicloxacillin
Number of subjects: 0
Study 9114989 — intervention group
Group type: COMPARATOR
Intervention: Oxacillin
Number of subjects: 0
Study 9114989 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin/Sulfisoxazole
Number of subjects: 0
Study 9114989 — intervention group
Group type: COMPARATOR
Intervention: Cefpodoxime
Number of subjects: 0
Study 7942325 — intervention group
Group type: EXPERIMENTAL
Intervention: aceclofenac
Number of subjects: 30
Study 7942325 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac
Number of subjects: 30
Study 7942325 — intervention group
Group type: EXPERIMENTAL
Intervention: aceclofenac and diclofenac
Number of subjects: 30
Study 3295676 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate therapy
Number of subjects: 18
Study 3295676 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 18
Study 31046405 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg/d for 3 days, then 250 mg/2 days for 3 months)
Number of subjects: 301
Study 31046405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 31046405 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 301
Study 27868230 — intervention group
Group type: EXPERIMENTAL
Intervention: Active continuous TENS (n=12)
Number of subjects: 24
Study 27868230 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS (n=12)
Number of subjects: 24
Study 26112044 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating (HE)
Number of subjects: 150
Study 26112044 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity (PA)
Number of subjects: 150
Study 26112044 — intervention group
Group type: COMPARATOR
Intervention: HE+PA
Number of subjects: 150
Study 23933267 — intervention group
Group type: EXPERIMENTAL
Intervention: Playground markings (EG)
Number of subjects: 420
Study 23933267 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 420
Study 21972329 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care for treating depression in patients with cardiac disease
Number of subjects: 0
Study 19632964 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up & Go (TUG) test for stroke subjects
Number of subjects: 44
Study 19632964 — intervention group
Group type: COMPARATOR
Intervention: Timed Up & Go (TUG) test for control subjects
Number of subjects: 44
Study 19632964 — intervention group
Group type: EXPERIMENTAL
Intervention: TUG trials for stroke subjects
Number of subjects: 44
Study 19632964 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of fear of falling with TUG performance in stroke subjects
Number of subjects: 44
Study 19632964 — intervention group
Group type: COMPARATOR
Intervention: Correlation of fear of falling with TUG performance in control subjects
Number of subjects: 44
Study 16722793 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 44
Study 16722793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 44
Study 16722793 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 44
Study 15246580 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR + AED units
Number of subjects: 0
Study 15246580 — intervention group
Group type: COMPARATOR
Intervention: CPR only units
Number of subjects: 0
Study 15246580 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR + AED method
Number of subjects: 0
Study 15246580 — intervention group
Group type: COMPARATOR
Intervention: CPR only approach
Number of subjects: 0
Study 11740216 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial ligation of silicone tube in Ahmed glaucoma valve implantation
Number of subjects: 32
Study 11740216 — intervention group
Group type: COMPARATOR
Intervention: Nonligation of silicone tube in Ahmed glaucoma valve implantation
Number of subjects: 32
Study 9247458 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention (anticipatory knowledge)
Number of subjects: 16
Study 9247458 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention plus somatic TENS
Number of subjects: 16
Study 9247458 — intervention group
Group type: COMPARATOR
Intervention: Distraction plus somatic TENS
Number of subjects: 16
Study 9247458 — intervention group
Group type: COMPARATOR
Intervention: Somatic TENS
Number of subjects: 16
Study 8495323 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute transverse colostomy, suture and omental covering of a visible perforation
Number of subjects: 62
Study 8495323 — intervention group
Group type: COMPARATOR
Intervention: Acute resection without primary anastomosis
Number of subjects: 62
Study 8495323 — intervention group
Group type: COMPARATOR
Intervention: Hartmann's procedure
Number of subjects: 62
Study 8495323 — intervention group
Group type: COMPARATOR
Intervention: Exteriorization of both lumens
Number of subjects: 62
Study 8495323 — intervention group
Group type: COMPARATOR
Intervention: Colostomy
Number of subjects: 62
Study 8495323 — intervention group
Group type: COMPARATOR
Intervention: Acute resection
Number of subjects: 62
Study 8495323 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute colostomy
Number of subjects: 62
Study 3320880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 10 mg intramuscular morphine and 10 mg oral cocaine
Number of subjects: 36
Study 3320880 — intervention group
Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 36
Study 3320880 — intervention group
Group type: COMPARATOR
Intervention: Cocaine alone
Number of subjects: 36
Study 3320880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 3320880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of morphine and cocaine
Number of subjects: 36
Study 29195117 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 448
Study 29195117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 448
Study 29195117 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 448
Study 29195117 — intervention group
Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 448
Study 29195117 — intervention group
Group type: COMPARATOR
Intervention: Unresectable disease
Number of subjects: 448
Study 27821103 — intervention group
Group type: EXPERIMENTAL
Intervention: 7‐day residential multidisciplinary team intervention
Number of subjects: 100
Study 27821103 — intervention group
Group type: COMPARATOR
Intervention: 6‐week physiotherapist‐led outpatient intervention (conventional care)
Number of subjects: 100
Study 26037084 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 116
Study 26037084 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 116
Study 23086987 — intervention group
Group type: EXPERIMENTAL
Intervention: PharmCAT
Number of subjects: 142
Study 23086987 — intervention group
Group type: EXPERIMENTAL
Intervention: Med‐eMonitor (MM)
Number of subjects: 142
Study 23086987 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 142
Study 20432354 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance angiography (MRA) using 20 mL of gadobenate dimeglumine
Number of subjects: 25
Study 20432354 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume rendering of 3D MRA
Number of subjects: 25
Study 17257431 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied 3 times a week for 4 weeks
Number of subjects: 17
Study 17257431 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 17
Study 15527629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramped position
Number of subjects: 60
Study 15527629 — intervention group
Group type: COMPARATOR
Intervention: Sniff position
Number of subjects: 60
Study 11806480 — intervention group
Group type: EXPERIMENTAL
Intervention: Er‐YAG laser conditioning (2.94 microm wavelength, 250 micros pulse duration, 300 mJ for enamel, 250 mJ for root surface, 2 Hz repetition rate)
Number of subjects: 10
Study 11806480 — intervention group
Group type: COMPARATOR
Intervention: Acid-etching with 35% phosphoric acid gel
Number of subjects: 10
Study 11806480 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 10
Study 9486674 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg/day + topical corticosteroid (diflucortolone valerate) for 6 weeks
Number of subjects: 60
Study 9486674 — intervention group
Group type: COMPARATOR
Intervention: Placebo + topical corticosteroid (diflucortolone valerate) for 6 weeks
Number of subjects: 60
Study 16856320 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (90 mg)
Number of subjects: 12
Study 16856320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3143511 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal patches containing 0.2 mA electrical current (active)
Number of subjects: 13
Study 3143511 — intervention group
Group type: COMPARATOR
Intervention: Transdermal patches containing no electrical current (passive)
Number of subjects: 13
Study 31387381 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment (n = 27 feet) with foot-ankle-hip exercise program, myofascial releasing, and joint and soft tissue mobilization techniques, twice a week for 8 weeks.
Number of subjects: 47
Study 31387381 — intervention group
Group type: COMPARATOR
Intervention: Home rehabilitation (n = 26 feet) with stretching and strengthening exercises only, completed independently over 8 weeks.
Number of subjects: 47
Study 29170075 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted behavioral activation intervention (REJOICE), 8 sessions, faith-based themes, Scripture, bible studies
Number of subjects: 24
Study 29170075 — intervention group
Group type: COMPARATOR
Intervention: Training only
Number of subjects: 24
Study 29170075 — intervention group
Group type: COMPARATOR
Intervention: Training + coaching calls
Number of subjects: 24
Study 27195696 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Review with Follow-up (MRF) service
Number of subjects: 1403
Study 27195696 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control Group - CG)
Number of subjects: 1403
Study 24554545 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with propofol, ketamine, and dexmedetomidine
Number of subjects: 119
Study 24554545 — intervention group
Group type: COMPARATOR
Intervention: Classic group (general anaesthesia with volatile anaesthetics and opioids)
Number of subjects: 119
Study 22397344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-community health worker (CHW) team
Number of subjects: 0
Study 22397344 — intervention group
Group type: COMPARATOR
Intervention: Community care (CC) group
Number of subjects: 0
Study 20089952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fingolimod 0.5 mg daily
Number of subjects: 1272
Study 20089952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fingolimod 1.25 mg daily
Number of subjects: 1272
Study 20089952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1272
Study 17592343 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/d of recombinant human growth hormone (r-hGH) for 12 weeks
Number of subjects: 325
Study 17592343 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of r-hGH on alternate days for maintenance (weeks 12-36)
Number of subjects: 325
Study 17592343 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 325
Study 17533709 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based oral health education program
Number of subjects: 0
Study 12579108 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobra aortic catheter
Number of subjects: 20
Study 10561055 — intervention group
Group type: EXPERIMENTAL
Intervention: MSSW with 0.2 g/L mineral content
Number of subjects: 36
Study 10561055 — intervention group
Group type: EXPERIMENTAL
Intervention: MSSW with 0.45 g/L mineral content
Number of subjects: 36
Study 10561055 — intervention group
Group type: EXPERIMENTAL
Intervention: MSSW with 5 g/L mineral content
Number of subjects: 36
Study 10561055 — intervention group
Group type: EXPERIMENTAL
Intervention: MSSW with 11 g/L mineral content
Number of subjects: 36
Study 8966165 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 30
Study 8966165 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 30
Study 1990160 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed vein graft
Number of subjects: 125
Study 1990160 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ vein graft
Number of subjects: 125
Study 1990160 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ vein graft (for veins <= 3.0 mm diameter)
Number of subjects: 125
Study 1990160 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed vein graft (for veins <= 3.0 mm diameter)
Number of subjects: 125
Study 1990160 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 125
Study 6350412 — intervention group
Group type: EXPERIMENTAL
Intervention: Polym (pilocarpine polymer)
Number of subjects: 40
Study 6350412 — intervention group
Group type: COMPARATOR
Intervention: Plc (traditional pilocarpine salt solution)
Number of subjects: 40
Study 31382136 — intervention group
Group type: COMPARATOR
Intervention: High-dose prednisone monotherapy (60 mg/day)
Number of subjects: 77
Study 31382136 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high-dose prednisone and moderate-dose topiramate (5 mg/kg/day)
Number of subjects: 77
Study 28350241 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-release dimethyl fumarate (DMF)
Number of subjects: 0
Study 28350241 — intervention group
Group type: COMPARATOR
Intervention: Glatiramer acetate (GA)
Number of subjects: 0
Study 25265994 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC(®)
Number of subjects: 56
Study 25265994 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope(®)
Number of subjects: 56
Study 23752090 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii stillness test
Number of subjects: 30
Study 23752090 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii agility test
Number of subjects: 30
Study 22990158 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 71
Study 22990158 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Sham
Number of subjects: 71
Study 22990158 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study 19164351 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 957
Study 19164351 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 957
Study 17126035 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious detection of errors while reading Chinese sentences
Number of subjects: 0
Study 17126035 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious detection of errors while reading Chinese sentences
Number of subjects: 0
Study 16036029 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (specific dosage not mentioned)
Number of subjects: 0
Study 16036029 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal doses of beta-blockers
Number of subjects: 0
Study 16036029 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of beta-blockers (target doses from large-scale studies)
Number of subjects: 0
Study 12585015 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention in established psychosis
Number of subjects: 0